MCK — Neutral (ASignal Rank 3/4)
ASignal's 10+ AI agent pipeline rates MCK as Neutral with 83% confidence in the Healthcare sector.
AI Analysis Summary
Avoid MCK due to weak fundamentals, bearish technicals, and conflicting valuation signals
Investment Framework Assessment
Evaluated through three legendary investor frameworks:
- Warren Buffett (Value Investing): Grade D — 35/100
- Bill Ackman (Activist Investing): Grade B — 68/100
- Ray Dalio (Macro/Risk Parity): Grade D — 42/100
Consensus: Bearish
Price Intelligence
- Current price: $828.11
- Price target: $966.64 (+16.7%)
- Risk level: high
- Horizon: medium term
Quality Assessment
- Balance sheet: concerning
- Cash flow: good
- Competitive moat: efficient scale
Peer Group Analysis
MCK is in the “Oversold & Compressed” cluster alongside ZBH, XOM, WFC, WDAY, VLO (128 stocks total). 0 of 128 peers are currently bullish.